Rheumatology Network reports: An international task force of multi-speciality experts says the "treat-to-target" approach can be applied just as effectively in systemic lupus erythematosus (SLE) as it has proven in rheumatoid arthritis.
A new study at Ohio State University of men and women with and without lupus strengthens the theory that estrogen may trigger the release of proteins called toll-like receptors that are involved in the autoimmune response.
Vaccination against shingles may be safe for patients with mild, stable systemic lupus erythematosus, according to a small pilot study conducted at the Oklahoma Medical Research Foundation in Oklahoma City
In a recent review article published in Arthritis Care & Research, the journal of the American College of Rheumatology (ACR), researchers at McGill University Health Centre (MUHC) point to the risks associated with using medical marijuana in advising healthcare providers to discourage its use by rheumatology patients.
The second Lupus Insight Prize will be announced at the upcoming professional FOCis meeting in Chicago June 25-28. This year focuses on translational immunology. The deadline for exhibitors is fast approaching on March 14.
This article in Ob.Gyn News reports on a study presented at a recent American College of Rheumatology symposium suggesting possible treatment for pregnant women with lupus to prevent fetal heart block.